FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207952631> ?p ?o ?g. }

• W3207952631 endingPage "17" @default.
• W3207952631 startingPage "5" @default.
• W3207952631 abstract "BACKGROUND: Cisplatin-based neoadjuvant chemotherapy is the standard of care for muscle invasive bladder cancer (MIBC). OBJECTIVE: To compare the efficacy and safety of the two most commonly used cisplatin-based regimens; gemcitabine, and cisplatin (GC) vs. accelerated (dose-dense: dd) or conventional methotrexate, vinblastine, adriamycin, and cisplatin (MVAC). METHODS: We searched MEDLINE, Embase, Scopus and other sources. Outcomes of interest included overall survival, downstaging to pT≤1, pathologic complete response (pCR), recurrence, and toxicity. Meta-analysis was conducted using the random-effects model. RESULTS: We identified 24 studies. Efficacy outcomes were comparable between MVAC and GC for MIBC. dd-MVAC was associated with favorable efficacy compared to GC in terms of downstaging (OR 1.45; 95%CI 1.15–1.82) and all-cause mortality at longest follow-up (OR 0.63; 95%CI 0.44–0.81). However, GC was associated with a better safety profile in terms of febrile neutropenia (OR 0.32; 95%CI 0.13–0.80), anemia (OR 0.32; 95%CI 0.18–0.54), nausea and vomiting (OR 0.27; 95%CI 0.12–0.65) compared to dd-MVAC. Compared to MVAC, patients receiving GC had an increased risk of developing grade 3–4 thrombocytopenia (OR 4.70; 95%CI 1.59–13.89) and a lower risk of nausea and vomiting (OR 0.05; 95%CI 0.01–0.31). Certainty in the estimates was very low for most outcomes. CONCLUSIONS: Efficacy and safety outcomes were comparable between MVAC and GC for MIBC. Including non-peer-reviewed studies showed higher efficacy with dd-MVAC. A phase III randomized trial comparing the two regimens is needed to guide clinical practice." @default.
• W3207952631 created "2021-10-25" @default.
• W3207952631 creator A5003873827 @default.
• W3207952631 creator A5023505548 @default.
• W3207952631 creator A5028031317 @default.
• W3207952631 creator A5028159293 @default.
• W3207952631 creator A5065716637 @default.
• W3207952631 creator A5070991589 @default.
• W3207952631 creator A5073495332 @default.
• W3207952631 creator A5080789872 @default.
• W3207952631 date "2022-03-11" @default.
• W3207952631 modified "2023-10-16" @default.
• W3207952631 title "Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer" @default.
• W3207952631 cites W1538189929 @default.
• W3207952631 cites W1845099892 @default.
• W3207952631 cites W1899700999 @default.
• W3207952631 cites W1975918912 @default.
• W3207952631 cites W1986710101 @default.
• W3207952631 cites W2026826756 @default.
• W3207952631 cites W2033585778 @default.
• W3207952631 cites W2073175347 @default.
• W3207952631 cites W2073804272 @default.
• W3207952631 cites W2078191480 @default.
• W3207952631 cites W2101562875 @default.
• W3207952631 cites W2103257412 @default.
• W3207952631 cites W2103561213 @default.
• W3207952631 cites W2103725052 @default.
• W3207952631 cites W2103818040 @default.
• W3207952631 cites W2104675861 @default.
• W3207952631 cites W2107328434 @default.
• W3207952631 cites W2122267678 @default.
• W3207952631 cites W2154121012 @default.
• W3207952631 cites W2156098321 @default.
• W3207952631 cites W2157823046 @default.
• W3207952631 cites W2160107406 @default.
• W3207952631 cites W2164791945 @default.
• W3207952631 cites W2166453367 @default.
• W3207952631 cites W2332342311 @default.
• W3207952631 cites W2559866572 @default.
• W3207952631 cites W2589678332 @default.
• W3207952631 cites W2782762180 @default.
• W3207952631 cites W2802899563 @default.
• W3207952631 cites W2807188318 @default.
• W3207952631 cites W2889395191 @default.
• W3207952631 cites W2922222000 @default.
• W3207952631 cites W2947295399 @default.
• W3207952631 cites W2977596818 @default.
• W3207952631 cites W2991792334 @default.
• W3207952631 cites W3008716617 @default.
• W3207952631 cites W4211115520 @default.
• W3207952631 cites W4313635027 @default.
• W3207952631 cites W884353920 @default.
• W3207952631 cites W2293692820 @default.
• W3207952631 doi "https://doi.org/10.3233/blc-201511" @default.
• W3207952631 hasPublicationYear "2022" @default.
• W3207952631 type Work @default.
• W3207952631 sameAs 3207952631 @default.
• W3207952631 citedByCount "2" @default.
• W3207952631 countsByYear W32079526312022 @default.
• W3207952631 countsByYear W32079526312023 @default.
• W3207952631 crossrefType "journal-article" @default.
• W3207952631 hasAuthorship W3207952631A5003873827 @default.
• W3207952631 hasAuthorship W3207952631A5023505548 @default.
• W3207952631 hasAuthorship W3207952631A5028031317 @default.
• W3207952631 hasAuthorship W3207952631A5028159293 @default.
• W3207952631 hasAuthorship W3207952631A5065716637 @default.
• W3207952631 hasAuthorship W3207952631A5070991589 @default.
• W3207952631 hasAuthorship W3207952631A5073495332 @default.
• W3207952631 hasAuthorship W3207952631A5080789872 @default.
• W3207952631 hasBestOaLocation W32079526311 @default.
• W3207952631 hasConcept C121608353 @default.
• W3207952631 hasConcept C126322002 @default.
• W3207952631 hasConcept C143998085 @default.
• W3207952631 hasConcept C2776694085 @default.
• W3207952631 hasConcept C2777063308 @default.
• W3207952631 hasConcept C2778239845 @default.
• W3207952631 hasConcept C2780258809 @default.
• W3207952631 hasConcept C2780352672 @default.
• W3207952631 hasConcept C2780580376 @default.
• W3207952631 hasConcept C2780852908 @default.
• W3207952631 hasConcept C71924100 @default.
• W3207952631 hasConceptScore W3207952631C121608353 @default.
• W3207952631 hasConceptScore W3207952631C126322002 @default.
• W3207952631 hasConceptScore W3207952631C143998085 @default.
• W3207952631 hasConceptScore W3207952631C2776694085 @default.
• W3207952631 hasConceptScore W3207952631C2777063308 @default.
• W3207952631 hasConceptScore W3207952631C2778239845 @default.
• W3207952631 hasConceptScore W3207952631C2780258809 @default.
• W3207952631 hasConceptScore W3207952631C2780352672 @default.
• W3207952631 hasConceptScore W3207952631C2780580376 @default.
• W3207952631 hasConceptScore W3207952631C2780852908 @default.
• W3207952631 hasConceptScore W3207952631C71924100 @default.
• W3207952631 hasIssue "1" @default.
• W3207952631 hasLocation W32079526311 @default.
• W3207952631 hasOpenAccess W3207952631 @default.
• W3207952631 hasPrimaryLocation W32079526311 @default.
• W3207952631 hasRelatedWork W2085978374 @default.
• W3207952631 hasRelatedWork W2100029565 @default.

• next